Please login to the form below
Kyowa Hakko Kirin
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Kyowa Hakko Kirin's 2012 Japan sales performance.
Finalists 2023
by Sciterion. for Kyowa Kirin International. XLH Matters – Driving Improved Care in XLH Through a Hybrid Meeting Approach. ... by Sciterion. for Kyowa Kirin International. Within – Stories from AstraZeneca’s Cancer@Work Employee Resource Group.
SMC enables access to Kyowa Kirin’s Crysvita for adults with rare genetic disease
Kyowa Kirin’s Crysvita (burosumab) will be made available via the ultra-orphan pathway, which will allow eligible adults with symptomatic XLH to access the treatment while the company collects additional ... While Scotland is currently the first in the
Amgen and Synaffix sign licensing agreement worth up to $2bn
The business model of Synaffix is target-specific technology out-licensing, shown through its existing deals with ADC Therapeutics, Mersana Therapeutics, Shanghai Miracogen, Innovent Biologics, ProfoundBio, Kyowa Kirin, Genmab, Macrogenics and
XLH Matters – A New Interactive Meeting Platform Raising Awareness of XLH
by Kyowa Kirin International with support from Sciterion. X-linked hypophosphataemia (XLH) is a rare, life-long, progressive disease. ... XLH Matters – A New Interactive Meeting Platform Raising Awareness of XLH - by Kyowa Kirin International with
XLH Matters – A New Interactive Meeting Platform Raising Awareness of XLH
by Kyowa Kirin International with support from Sciterion. X-linked hypophosphataemia (XLH) is a rare, life-long, progressive disease. ... XLH Matters – A New Interactive Meeting Platform Raising Awareness of XLH - by Kyowa Kirin International with
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Sanofi's frexalimab shows promise in relapsing forms of MS
- How an AI algorithm might save your life
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Seqera Labs and Genomics England partner to progress genomic research
- Whitepaper: Closing the gap with compelling healthcare communications
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
No results were found
PMHub
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....
Latest intelligence
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
